Fig. 3: TTNT by cytogenetic group. | Blood Cancer Journal

Fig. 3: TTNT by cytogenetic group.

From: Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

Fig. 3

Comparison of the time to next treatment (TTNT) between patients with high-risk IgH translocations (red curve), those with standard-risk IgH translocations (green curve), and those with trisomies without IgH translocation (blue curve) receiving a PI-based, b IMiD-based, c PI + IMiD-based treatment and d other treatments. IgH immunoglobulin heavy chain, IMiD immunomodulatory drug, PI proteasome inhibitor.

Back to article page